Functional foods for childhood development

Alternative and Complementary Therapies

Volumn 10, Issue 3, 2004, Pages 131-134

  Barker, Jason ^a   Meletis, Chris D ^b  

^a Healthmax   (United States)

^b Pearl Clinic and Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; PROBIOTIC AGENT; ZINC;

ATTENTION DEFICIT DISORDER; CHILD DEVELOPMENT; CHILD NUTRITION; FAT INTAKE; FOOD COMPOSITION; HUMAN; NUTRITIONAL REQUIREMENT; REVIEW; ZINC METABOLISM;

EID: 3042628316     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/1076280041138270     Document Type: Review

References (25)

1. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the eye. J Am Coll Nutr 2001;20:106-118.
2. Freake HC, Govoni KE, Guda K, et al. Actions and interactions of thyroid hormone and zinc status in growing rats. J Nutr 2001;4:1135-1141.
3. Barceloux DG. Zinc. J Toxicol Clin Toxicol 1999;37:279-292.
4. Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York, NY: Stonesong Press, 1999.
5. Black MM. Zinc deficiency and child development. Am J Clin Nutr 1998;68(2[suppl]):464S-469S.
6. Favier AE. Hormonal effects of zinc on growth in children. Biol Trace Elem Res 1992;32:383-398.
7. King JC. Enhanced zinc utilization during lactation may reduce maternal and infant zinc depletion. Am J Clin Nutr 2002;75:2-3.
8. Roberts LJ, Shadwick CF, Bergstresser PR. Zinc deficiency in two full-term breast-fed infants. J Am Acad Dermatol 1987;16(2[pt 1]):301-304.
9. Siberry GK, Ruff AJ, Black R. Zinc and human immunodeficiency virus infection. Nutr Res 2002;22:527-538.
10. Galland L. Nutritional supplementation for ADHD. In: Bellanti JA, Crook WG, Layton RE, eds. Attention Deficit Hyperactivity Disorder: Causes and Possible Solutions [proceedings of a conference]. Jackson, TN: International Health Foundation, 1999.
11. Toren P, Eldar S, Sela BA, et al. Zinc deficiency in attention-deficit hyperactivity disorder. Biol Psychiatry 1996;40:1308-1310.
12. Bilici M, Yildirim F, Kandil S, Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:181-190.
13. Bekaroglu M, Aslan Y, Gedik Y, Deger O, Mocan H, Erduran E, Karahan C. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: A research note. J Child Psychology Psychiatry 1996;37:225-227.
14. Cocores JA, Davies RK, Mueller PS, Gold MS. Cocaine abuse and adult attention deficit disorder. J Clin Psychiatry 1987;48:376-377.
15. Wainwright P. Nutrition and behaviour: The role of n-3 fatty acids in cognitive function. Br J Nutr 2000;83:337-339.
16. Gibson RA. Long-chain polyunsaturated fatty acids and infant development. Lancet 1999;354:1919.
17. Moriguchi T, Greiner RS, Salem N Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000;75:2563-7253.
18. Koo WW. Efficacy and safety of docosahexaenoic acid and arachidonic acid addition to infant formulas: Can one buy better vision and intelligence? J Am Coll Nutr 2003;22(2):101-107.
19. Gamoh S, Hashimoto M, Sugioka K, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999;93:237-241.
20. Willatts P. Long chain polyunsaturated fatty acids improve cognitive development. J Fam Health Care 2002;12(6[suppl]):5.
21. Voigt RG, Jensen CL, Fraley JK, Rozelle JC, Brown FR 3rd, Heird WC. Relationship between omega 3 long-chain polyunsaturated fatty acid status during early infancy and neurodevelopmental status at 1 year of age. J Hum Nutr Diet 2002;15:111-120.
22. Williams C, Birch EE, Emmett PM, Northstone K, Avon Longitudinal Study of Pregnancy and Childhood Study Team. Stereoacuity at age 3.5 years in children born full-term is associated with prenatal and postnatal dietary factors: A report from a population-based cohort study. Am J Clin Nutr 2001;73:316-322.
23. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109:119-121.
24. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;31;361:1869-1871.
25. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001;7;357:1076-1079